Sucampo Pharmaceuticals, Inc. (SPI), a global pharmaceutical company, and Abbott have introduced Amitiza (lubiprostone) in Japan, a prescription medicine for the treatment of chronic constipation not ...
Sucampo Pharma, Ltd., a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc. (SPI) has received approval from the Ministry of Health, Labor and Welfare in Japan for Amitiza (lubiprostone), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback